Sarcopenia, Obesity, and Resistance Training

Effects of Resistance Training on Sarcopenic Obesity Index in Older Women: a RCT.

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02681744

Enrollment

244

Registered

2016-02-12

Start date

2016-02-29

Completion date

2016-08-31

Last updated

2016-02-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aging, Obesity, Sarcopenia

Brief summary

The purpose of this study was to examine the effects of resistance training on sarcopenic obesity in older women.

Detailed description

To examine the effects of resistance training on sarcopenic obesity in older women, a representative sample of older women from Brasília, Brazil (n\>244 subjects), will be recruited and invited to undergo body composition measurement using dual-energy x-ray absorptiometry. Moreover, the Sarcopenic Obesity index and isokinetic strength evaluations will be performed. It will be a single-blind randomized, controlled 24-week clinical trial, in which experimental group will receive a progressive resistance training program, meanwhile control group will receive instructions to maintain their lifestyle habits. Randomization will be conducted by computer-generated list in blocks of 10. Additionally, body composition, strength assessment, and sarcopenic index will collected and compared after the intervention period.

Interventions

BEHAVIORALResistance Training

24-weeks of progressive strength training

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

SUPPORTIVE_CARE

Masking

SINGLE (Investigator)

Eligibility

Sex/Gender

FEMALE

Age

60 Years to 80 Years

Healthy volunteers

Yes

Inclusion criteria

* Community older women (aged between 60 and 80 years).

Exclusion criteria

* individuals with any metallic implant or artificial pacemaker, who had undergone hip surgery, who were unable to walk without assistance and those affected by metabolic or endocrine disorders that affect the muscular system.

Design outcomes

Primary

Measure	Time frame	Description
Laboratorial Body Composition assessment (DXA)	30 minutes	DXA-derived body fat and DXA-derived fat free mass

Secondary

Measure	Time frame	Description
Isokinetic peak torque of leg extension (dynamometer isokinetic)	20 minutes	Dominant leg extension peak torque will be recorded in three sets of maximal effort

Countries

Brazil

Contacts

Primary ContactRicardo M Lima, PhD

gefsunb@gmail.com+556184908490

Backup ContactAndré B Gadelha, MSc

andrebonadias@gmail.com+556181880231

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026